Summary.
A series of substituted pyridine derivatives were prepared from 3-acetylpyridine, which was prepared from the corresponding nicotinic acid as a natural starting material. Reaction of 3-acetylpyridine with indole-3-carboxaldehyde afforded the corresponding 3-β-(3-indolyl)acryloylpyridine, which was reacted with hydroxylamine hydrochloride in pyridine or acetic acid in the presence of sodium acetate to afford 3-β-(3-indolyl)acryloylpyridine oxime and oxazole derivatives. The oxime was treated with ethyl isothiocyanate or toluene-3,5-diisocyanate in refluxing dioxane to give the corresponding ethyl thiosemicarbazide and 3,5-bissemicarbazide derivative. 3-β-(3-Indolyl)acryloylpyridine was condensed with malononitrile in refluxing ethanol in the presence of piperidine as a catalyst to give cyanoaminopyrane, while it was condensed with ethyl cyanoacetate or malononitrile in the presence of ammonium acetate to yield cyanopyridone and cyanoaminopyridine derivatives. Cyclization of acryloylpyridine with o-phenylenediamine in refluxing butanol led to the formation of the corresponding benzodiazipine via the intermediate A. Finally, cycloaddition reaction of acryloylpyridine with thiourea yielded thioxopyrimidine, which was treated with chloroacetic acid to yield thiazolopyrimidine. An arylmethylene derivative was prepared by reacting thiazolopyrimidine with indole-3-carboxaldehyde or by reacting thioxopyrimidine with indole-3-carboxaldehyde and chloroacetic acid in one step. The pharmacological screening showed that many of these obtained compounds have good analgesic and anticonvulsant activities comparable to Valdecoxib® and Carbamazepine® as reference drugs.
Similar content being viewed by others
References
NA Abdel-Latif (2005) Scientia Pharmaceutica 74 193
AE Amr NA Abdel-Latif MM Abdalla (2006) Acta Pharm 56 203 Occurrence Handle1:CAS:528:DC%2BD28XltValsLw%3D
AE Amr NA Abdel-Latif MM Abdalla (2006) Bioorg Med Chem 14 273 Occurrence Handle10.1016/j.bmc.2005.08.023
AE Amr (2005) Z Naturforsch 60b 990
AE Amr HH Sayed MM Abdulla (2005) Arch Pharm Chem Life Sci 338 433 Occurrence Handle10.1002/ardp.200500982 Occurrence Handle1:CAS:528:DC%2BD2MXhtV2hu73J
MH Abo-Ghalia AE Amr (2004) Amino Acids 26 283 Occurrence Handle15221509 Occurrence Handle10.1007/s00726-003-0042-8 Occurrence Handle1:CAS:528:DC%2BD2cXkvF2ms74%3D
AG Hammam AFM Fahmy AE Amr AM Mohamed (2003) Ind J Chem 42B 1985 Occurrence Handle1:CAS:528:DC%2BD3sXms1Wgt7c%3D
Mc El-Vain (1925) Org Syn 4 49
MH Abo Ghalia EMS Salem (1980) Ind J Chem 19B 135
MH Abo Ghalia EMS Salem S Shoeb M Zedan (1979) Polish J Chem 53 2239 Occurrence Handle1:CAS:528:DyaL3cXksVOisb0%3D
AM Bunker JJ Edmund KA Berryman DN Walker MA Flynn KM Welch AM Doherty (1996) Bioorg Med Chem Lett 6 1061 Occurrence Handle10.1016/0960-894X(96)00170-9 Occurrence Handle1:CAS:528:DyaK28XjtFCksbY%3D
X Yao-Chang KW Johnson LA Phebus M Cohen DL Nelson K Schenk CD Walker JE Fritz SW Kolder NE Letourneau RE Murff JM Zgombick DO Calligaro JE Audia JM Schaust (2001) J Med Chem 44 4031 Occurrence Handle10.1021/jm0155190
C Bailly L Dassonneville P Colson C Houssier K Fukasawa S Nishimura T Yoshinari (1999) Cancer Res 59 2853 Occurrence Handle10383146 Occurrence Handle1:CAS:528:DyaK1MXktVOku7o%3D
AH van Hattum HM Pinedo HNM Schluper CAM Erkelens A Tongo E Boven (2002) Biochem Pharm 64 1267 Occurrence Handle12234607 Occurrence Handle10.1016/S0006-2952(02)01297-2 Occurrence Handle1:CAS:528:DC%2BD38XntVWqtrk%3D
L He X Chang TC Chou N Savaraj CC Cheng (2003) Eur J Med Chem 38 101 Occurrence Handle12593920 Occurrence Handle10.1016/S0223-5234(02)01420-4 Occurrence Handle1:CAS:528:DC%2BD3sXht1yqtrk%3D
H Sugiyama F Yokokawa T Aoyama T Shiori (2001) Tetrahedron Lett 42 7277 Occurrence Handle10.1016/S0040-4039(01)01492-7 Occurrence Handle1:CAS:528:DC%2BD3MXmvFCjsrw%3D
CG Yang G Liu B Jiany (2002) J Org Chem 67 9392 Occurrence Handle12492343 Occurrence Handle10.1021/jo026450m Occurrence Handle1:CAS:528:DC%2BD38XovFSku7s%3D
Y Min M Borgne F Pagnez G Baut P Pape (2003) Eur J Med Chem 38 75 Occurrence Handle10.1016/S0223-5234(02)00005-3
AE Amr MI Hegab AA Ibrahim MM Abdalah (2003) Monatsh Chem 134 1395 Occurrence Handle1:CAS:528:DC%2BD3sXnvVWrurs%3D
AE Amr MM Abdulla (2002) Ind J Heterocycl Chem 12 129 Occurrence Handle1:CAS:528:DC%2BD3sXkvVWiug%3D%3D
A Attia OI Abdel-Salam MH Abou-Ghalia AE Amr (1995) Egypt J Chem 38 543 Occurrence Handle1:CAS:528:DyaK28Xitl2jt7o%3D
A Attia OI Abdel-Salam AE Amr (2000) Egypt J Chem 43 297 Occurrence Handle1:CAS:528:DC%2BD3cXptFSnsr4%3D
A Attia OI Abdel-Salam AE Amr (1997) Egypt J Chem 40 317 Occurrence Handle1:CAS:528:DyaK2sXmslCrtrk%3D
Kligler IJ, Grossowicz N (1941) J Bact 42: 173; C A 35: 10886 (1941)
A Attia M Michael (1983) Acta Chimica Hungarica 114 337 Occurrence Handle1:CAS:528:DyaL2cXitV2ksb4%3D
Salmula K, Ewa JK (1974) Bocz Chem 48: 2287; CA 43: 79207t (1975)
W Ried P Staphlofen (1954) Chem Ber 87 1814 Occurrence Handle1:CAS:528:DyaG28Xhs1Si
J Lhfield F Wilcoxon (1949) J Pharmacol Exp Ther 96 99
A Tgolsen GH Rofland OG Berge K Hole (1991) J Pharmacol Ther 25 241
R Dunm S Fielding (1987) Drug Rev Res 10 177
KF Austen WE Brocklehurst (1961) J Exp Med 113 521 Occurrence Handle13685194 Occurrence Handle10.1084/jem.113.3.521 Occurrence Handle1:CAS:528:DyaF3MXotF2qtA%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abd El-Latif, N., Amr, AG. & Ibrahiem, A. Synthesis, Reactions, and Pharmacological Screening of Heterocyclic Derivatives Using Nicotinic Acid as a Natural Synthon. Monatsh. Chem. 138, 559–567 (2007). https://doi.org/10.1007/s00706-007-0628-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-007-0628-z